Recruiting
Phase 1

Orca-T, CAR T Cells

Sponsor:

Melody Smith

Code:

NCT05507827

Conditions

Lymphoid Leukemia

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)

Treg CD34+HSPC (Orca-T)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Melody Smith on 2025-03-21.